Alzinova AB (publ) (ALZ.ST)

SEK 2.02

(1.46%)

Long Term Debt Summary of Alzinova AB (publ)

  • Alzinova AB (publ)'s latest annual long term debt in 2023 was 800 Thousand SEK , down 0.0% from previous year.
  • Alzinova AB (publ)'s latest quarterly long term debt in 2024 Q2 was 800 Thousand SEK , down 0.0% from previous quarter.
  • Alzinova AB (publ) reported annual long term debt of 800 Thousand SEK in 2022, down 0.0% from previous year.
  • Alzinova AB (publ) reported annual long term debt of 800 Thousand SEK in 2021, down 0.0% from previous year.
  • Alzinova AB (publ) reported quarterly long term debt of 800 Thousand SEK for 2024 Q2, down 0.0% from previous quarter.
  • Alzinova AB (publ) reported quarterly long term debt of 800 Thousand SEK for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Alzinova AB (publ) (2023 - 2012)

Historical Annual Long Term Debt of Alzinova AB (publ) (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 800 Thousand SEK 0.0%
2022 800 Thousand SEK 0.0%
2021 800 Thousand SEK 0.0%
2020 800 Thousand SEK 0.0%
2019 800 Thousand SEK 0.0%
2018 800 Thousand SEK 0.0%
2017 800 Thousand SEK 0.0%
2016 800 Thousand SEK 3.87%
2015 770.18 Thousand SEK 92.55%
2014 400 Thousand SEK 0.0%
2013 400 Thousand SEK 0.0%
2012 - SEK 0.0%

Peer Long Term Debt Comparison of Alzinova AB (publ)

Name Long Term Debt Long Term Debt Difference
Active Biotech AB (publ) 3 Million SEK 73.333%
Biovica International AB (publ) 4.29 Million SEK 81.378%
Cantargia AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Cyxone AB (publ) 74 Thousand SEK -981.081%
Diagonal Bio AB (publ) - SEK -Infinity%
Elicera Therapeutics AB (publ) - SEK -Infinity%
ExpreS2ion Biotech Holding AB (publ) 1.43 Million SEK 44.29%
Fluicell AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Mendus AB (publ) 850 Thousand SEK 5.882%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Intervacc AB (publ) 142 Thousand SEK -463.38%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Magle Chemoswed Holding AB (publ) 32.58 Million SEK 97.545%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
OncoZenge AB (publ) - SEK -Infinity%
Sprint Bioscience AB (publ) - SEK -Infinity%
Xbrane Biopharma AB (publ) 112.89 Million SEK 99.291%
Lipum AB (publ) 1.76 Million SEK 54.571%
Alligator Bioscience AB (publ) 7.51 Million SEK 89.356%
Ziccum AB (publ) 286 Thousand SEK -179.72%
BioArctic AB (publ) 2.15 Million SEK 62.825%
Genovis AB (publ.) 74.8 Million SEK 98.931%
Camurus AB (publ) 13.61 Million SEK 94.123%
IRLAB Therapeutics AB (publ) 24.51 Million SEK 96.736%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) - SEK -Infinity%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Xspray Pharma AB (publ) 31.94 Million SEK 97.496%
Kancera AB (publ) - SEK -Infinity%
Saniona AB (publ) 65.23 Million SEK 98.774%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -88.679%
Karolinska Development AB (publ) - SEK -Infinity%
Amniotics AB (publ) - SEK -Infinity%
2cureX AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK 20.0%
Calliditas Therapeutics AB (publ) 939.5 Million SEK 99.915%
Hansa Biopharma AB (publ) 844.9 Million SEK 99.905%
Biosergen AB - SEK -Infinity%
QuiaPEG Pharmaceuticals Holding AB (publ) - SEK -Infinity%
Corline Biomedical AB - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Nanologica AB (publ) 136 Thousand SEK -488.235%
LIDDS AB (publ) - SEK -Infinity%
Egetis Therapeutics AB (publ) 103.4 Million SEK 99.226%
BioInvent International AB (publ) 14.53 Million SEK 94.496%
SynAct Pharma AB 58 Thousand SEK -1279.31%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK 5.882%
Ascelia Pharma AB (publ) 176 Thousand SEK -354.545%
Oncopeptides AB (publ) 106.48 Million SEK 99.249%
Pila Pharma AB (publ) - SEK -Infinity%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 99.118%
Diamyd Medical AB (publ) 30.67 Million SEK 97.392%